VolitionRx Limited Liabilities, Fair Value Adjustment
VolitionRx Limited (VNRX) reported Liabilities, Fair Value Adjustment of -$339.74 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-11.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:LiabilitiesFairValueAdjustment · last filed 2016-03-11
- VolitionRx Limited liabilities, fair value adjustment for the quarter ending 2015-12-31 was $0.00.
- VolitionRx Limited liabilities, fair value adjustment for the quarter ending 2015-09-30 was $0.00.
- VolitionRx Limited liabilities, fair value adjustment for the quarter ending 2015-06-30 was $0.00.
- VolitionRx Limited liabilities, fair value adjustment for the quarter ending 2015-03-31 was -$339.74K.
- VolitionRx Limited liabilities, fair value adjustment for fiscal 2015 was -$339.74K, a 123.85% decline from fiscal 2014.
- VolitionRx Limited liabilities, fair value adjustment for fiscal 2014 was $1.42M.
| Period end | Liabilities, Fair Value Adjustment 3 month | Liabilities, Fair Value Adjustment 6 month | Liabilities, Fair Value Adjustment 9 month | Liabilities, Fair Value Adjustment 12 month |
|---|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $0.00 derived: sum of 2 quarters · filed 2016-03-11 | $0.00 derived: sum of 3 quarters · filed 2016-03-11 | -$339.74K 10-K · filed 2016-03-11 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $0.00 derived: sum of 2 quarters · filed 2015-11-04 | -$339.74K 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | -$339.74K 10-Q · filed 2015-08-11 | ||
| 2015-03-31 | -$339.74K 10-Q · filed 2015-05-12 | |||
| 2014-12-31 | $1.42M 10-K · filed 2015-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |